Management of Hodgkin lymphoma

Mayo Clinic Proceedings
Stephen M Ansell, James O Armitage

Abstract

Approximately 7350 new cases of Hodgkin lymphoma (HL) are diagnosed annually in the United States. The Incidence of HL has a bimodal pattern, with the highest incidence seen in young adults and in elderly patients. The disease is composed of 2 distinct entities: the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. Classical HL includes the subgroups nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte rich. Selection of the appropriate therapy Is based on accurately assessing the stage of disease. Patients with early-stage disease are treated with combined modality strategies using abbreviated courses of combination chemotherapy followed by Involved-field radiation therapy, whereas those with advanced-stage disease receive a longer course of chemotherapy without radiation therapy. Currently, more than 80% of all patients with newly diagnosed HL are expected to be long-term survivors. Although many patients respond well to initial therapies and have durable long-term remissions, a subset of patients has resistant disease and experiences relapse even after subsequent high-dose chemotherapy and autologous stem cell transplantation. New therapies are clearly needed for these...Continue Reading

References

Feb 3, 1977·The New England Journal of Medicine·S GruffermanR J Lukes
Nov 19, 1992·The New England Journal of Medicine·G P CanellosB A Peterson
Jan 1, 1992·Cancer Investigation·H T LynchJ F Lynch
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S VivianiP Valagussa
Oct 1, 1981·The American Journal of Medicine·R L SchilskyV T DeVita
Jan 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J HorningR T Hoppe
Aug 1, 1996·Leukemia & Lymphoma·L DevizziG Bonadonna
Sep 1, 1996·Baillière's Clinical Haematology·S L Glaser, R F Jarrett
Jan 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L DevizziG Bonadonna
Oct 16, 1999·American Journal of Human Genetics·M Horwitz, P H Wiernik
Feb 17, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SieberA Jostin
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Colin D WeekesUNKNOWN Nebraska Lymphoma Study Group
Jun 25, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T ChisesiUNKNOWN Intergruppo Italiano Linfomi
Feb 15, 2003·Blood·Bradley C EkstrandSandra J Horning
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David B DugganBruce A Peterson
May 14, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Michael MazonakisJohn Damilakis
Jun 13, 2003·The New England Journal of Medicine·Volker DiehlUNKNOWN German Hodgkin's Lymphoma Study Group
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoUNKNOWN EBMT/GISL/ANZLG/SFGM/GELA Intergroup HD01 Trial
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
May 3, 2005·The Lancet Oncology·Henk B Kal, Henk Struikmans
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo G GobbiUNKNOWN Intergruppo Italiano Linfomi
May 23, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellPeter Borchmann
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franck MorschhauserUNKNOWN GELA/SFGM Study Group
Nov 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Fernández de LarreaE Carreras

❮ Previous
Next ❯

Citations

Sep 5, 2008·Blood·Vincent RibragUNKNOWN Groupe d'Etude des Lymphomes agressifs group, Laboratoire de Génétique et de recherche translationnelle, and Institut Gustav
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Afonso José Pereira CortezDalton de Alencar Fischer Chamone
Jun 21, 2011·Advances in Hematology·S E Richardson, C McNamara
Sep 8, 2015·Vaccines·Giovanni CaponeDarja Kanduc
Dec 3, 2010·Expert Opinion on Investigational Drugs·Stephen M Ansell
Jul 15, 2015·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J A Ortega-GarcíaJ L Fuster-Soler
Aug 26, 2010·Regulatory Toxicology and Pharmacology : RTP·Philip ColeJack Mandel
Aug 4, 2009·Emergency Medicine Clinics of North America·Kellie J Nazemi, Suman Malempati
Feb 9, 2007·Mayo Clinic Proceedings·Alex A AdjeiAyalew Tefferi
Jan 1, 2007·Mayo Clinic Proceedings·William L Lanier
Jul 1, 2008·Magnetic Resonance Imaging Clinics of North America·Marilyn J Siegel, Ellen M Chung
Jan 11, 2007·Seminars in Pediatric Surgery·Thomas F Tracy, Christopher S Muratore
May 27, 2009·British Journal of Haematology·Andres Forero-TorresAjay K Gopal
Feb 23, 2007·Cancer·M Jane TetaMeghan E Wagner
Jan 22, 2013·International Journal of Cancer. Journal International Du Cancer·Liliane ChatenoudCarlo La Vecchia
Mar 22, 2016·Cancer Medicine·Matthew KoshyUsama Mahmood
Dec 16, 2010·Clinical Lymphoma, Myeloma & Leukemia·Christopher R Flowers, James O Armitage
Feb 2, 2010·Hematology/oncology and Stem Cell Therapy·Lucille WoodPeter Jacobs
May 3, 2007·Clinical Journal of Oncology Nursing·Kimberly Noonan
Dec 22, 2010·European Journal of Medical Research·T UrasinskiA Walecka
May 23, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellPeter Borchmann
Mar 23, 2012·Medicine, Science, and the Law·Laura Di PietraClaudio Terranova
Aug 30, 2011·Virchows Archiv : an International Journal of Pathology·Mona A A ZakiKatsuyuki Aozasa
Apr 30, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Bahram TahmasbyAsma Sabermahani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Preethi R Marri, Stephen M Ansell
Journal of the National Comprehensive Cancer Network : JNCCN
Joachim Yahalom
International Journal of Hematology
Dennis A Eichenauer, A Engert
© 2021 Meta ULC. All rights reserved